Markets:

Overview

News

Currencies

International

Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

94.65 +3.43 (+3.76%)

Streaming Delayed Price Updated: 11:35 AM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AstraZeneca PLC - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

74 75 Next >

Dow Futures Edge Lower As Investors Exercise Caution After S&P 500’s Record High: GM, KO, NXPI, AZN Among Stocks To Watch ↗

July 22, 2025

While Dow Jones futures were down 0.01% at the time of writing, the S&P 500 futures fell 0.09%.

Via Stocktwits

Topics ETFs Government Stocks

AstraZeneca Bets Big On America With $50B Investment, New Virginia Hub Plans Amid Pharma Tariff Jitters ↗

July 21, 2025

At the center of the company’s plan is a new, multi-billion-dollar manufacturing facility in Virginia.

Via Stocktwits

Topics Artificial Intelligence Government World Trade

AstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer ↗

July 21, 2025

AstraZeneca's Tagrisso with chemo significantly improves survival and progression-free outcomes in EGFR-mutant NSCLC, final trial data shows.

Via Benzinga

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D

July 21, 2025

From AstraZeneca

Via Business Wire

AstraZeneca Stock Rises As Experimental Drug Lowers Blood Pressure In Late-Stage Study, Retail’s Yet To React ↗

July 14, 2025

Via Stocktwits

Price Over Earnings Overview: AstraZeneca ↗

July 02, 2025

Via Benzinga

TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer

July 21, 2025

From AstraZeneca

Via Business Wire

JPMorgan Goes Global With HOLA ETF—Stocks Plus Built‑In Crash Protection ↗

July 16, 2025

JPMorgan AM launched HOLA, an ETF that aims to generate income from foreign equities while mitigating risk through a laddered options overlay.

Via Benzinga

Topics ETFs

AstraZeneca's Experimental Therapy Stumbles In Late-Stage Study For Rare Protein Deposit Condition ↗

July 16, 2025

AstraZeneca's anselamimab missed the main goal in a Phase 3 AL amyloidosis trial but showed promising benefit in a defined patient subgroup.

Via Benzinga

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' ↗

July 16, 2025

Barclays has said that it's hard to predict which firm would be affected the most by pharma tariffs, except for Novo Nordisk.

Via Benzinga

Topics Government World Trade

GSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults ↗

July 15, 2025

FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the first half of 2026.

Via Benzinga

AstraZeneca's Drug Shows Promise For Resistant Hypertension In Phase 3 Trial ↗

July 14, 2025

AstraZeneca's Phase 3 trial showed baxdrostat lowered systolic blood pressure in treatment-resistant hypertension with a favorable safety profile.

Via Benzinga

Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension

July 14, 2025

From AstraZeneca

Via Business Wire

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

July 12, 2025

The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the week and a look at the catalysts that could be driving the attention.

Via Benzinga

Why Is AbbVie Stock Trading Higher On Thursday? ↗

July 10, 2025

AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase clinical data.

Via Benzinga

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug ↗

July 09, 2025

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's looming patent loss.

Via Benzinga

Topics Intellectual Property

Dow Futures Edge Up As Trump Prepares More Tariff Letters: Freeport, UnitedHealth, Meta, Novo Nordisk, AstraZeneca Among Stocks In Focus ↗

July 09, 2025

While Dow Jones futures edged up by 0.17% at the time of writing, the S&P 500 futures were up 0.15%.

Via Stocktwits

Topics ETFs Government Stocks

Artelo Biosciences Analyst See It As An Emerging Biotech ↗

July 08, 2025

Artelo gets Buy rating from Boral Capital after positive updates on ART27.13, ART26.12, and preclinical success of its candidate for depression.

Via Benzinga

Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

July 08, 2025

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MBIO),(NASDAQ:VSTM),(NASDAQ:CRDF),(NASDAQ:AZN) EQNX::TICKER_END

Via FinancialNewsMedia

NIKE, Datadog And Snap Are Among Top 11 Large Cap Gainers Last Week (June 30-July 4): Are The Others In Your Portfolio? ↗

July 06, 2025

11 best performing large-cap stocks last week, including Symbotic, Nike, First Solar, Datadog, HPE, Summit Therapeutics, Carnival, POSCO, Wynn Resorts, SharkNinja, and Snap

Via Benzinga

Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

July 08, 2025

From FN Media Group LLC

Via GlobeNewswire

Why AstraZeneca Stock Got Thumped on Thursday ↗

July 03, 2025

Via The Motley Fool

AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment ↗

July 03, 2025

Via Benzinga

AstraZeneca In Talks To License Summit Therapeutics’ Experimental Lung Cancer Drug: Report ↗

July 03, 2025

While the terms of the partnership agreement are still being negotiated, it could include an upfront payment worth several billion dollars and milestone payments, Bloomberg reported, while noting that...

Via Stocktwits

Why AstraZeneca Stock Topped the Market on Tuesday ↗

July 01, 2025

Via The Motley Fool

Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment? ↗

June 30, 2025

The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide.

Via Investor's Business Daily

3 No-Brainer Stocks to Buy for Under $100 Right Now ↗

June 28, 2025

Via The Motley Fool

Topics Intellectual Property

Trump Vows To Cut 'The Best Deal' On Drug Prices. What To Expect. ↗

June 26, 2025

President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy.

Via Investor's Business Daily

Topics Government

DATROWAY® approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

June 24, 2025

From AstraZeneca

Via Business Wire

FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For EGFR-Mutated Lung Cancer ↗

June 24, 2025

FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response rate and a $45 million milestone due.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

74 75 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.